University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 5 of 26
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
NCT06518746
Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD
NCT04796506
Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients
NCT05064098
Premature Discontinuation of Contraceptive Implants
NCT04828824
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
NCT04993859
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
NCT04137835
HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots
NCT04979728
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
NCT04404101
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
NCT04544592
Home Based Infusions for Ocrelizumab
NCT04650321
A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures
NCT04515316
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
NCT04596592
International CDKL5 Clinical Research Network
NCT05558371
Brexpiprazole in Alcohol Use Disorder
NCT04066192
Personalized Spine Study Group (PSSG) Registry
NCT04601363
The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
NCT04513782
Testicular Tissue Cryopreservation (TTC)
NCT06387498
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
NCT04611022
Puberty Suppression and Cardiometabolic Health
NCT04482374
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
NCT05052606
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
NCT03958565
Suicide in Urban Natives: Detection and Networks to Combat Events
NCT03136094
Creative Arts Program to Reduce Burnout in Healthcare Professionals
NCT04276922
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
NCT04028063
Uric Acid Lowering Trial in Youth Onset T2D
NCT03899883
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
NCT04059172
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
NCT03881098
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
NCT04040959
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
NCT03995082
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
NCT04066296
Losartan + Sunitinib in Treatment of Osteosarcoma
NCT03900793
Bright Light Exposure in Surgical Patients
NCT03822949
Comparison of Patient-reported Pain After Initial Archwire Placement
NCT03906422
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
NCT03797183
Fetoscopic Endoluminal Tracheal Occlusion
NCT03674372
ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis
NCT03404258
The Genetics of Pulmonary Fibrosis
NCT03478553
The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy
NCT03396562
Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
NCT03215836
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
NCT03297775
Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition
NCT03626194
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
NCT02315729
Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers
NCT03076658
The Human Trisome Project
NCT02864108
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
NCT03042221
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
NCT03014401
Effects of High Altitude on AMPK Activation
NCT02391519
Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response
NCT02480283
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
NCT02090140
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.